Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System To Revolutionize Diabetes Management

· The best-selling real-time CGM in the world^¹ is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app
· New system has the fastest sensor warmup on the market,* with no fingersticks^† or scanning required
· Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range^²,³

EDINBURGH, Scotland & SAN DIEGO, March 15 (Bernama-BUSINESS WIRE) — DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.

http://mrem.bernama.com/viewsm.php?idm=42657